These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 3009608

  • 1. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
    Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH.
    J Immunol; 1986 May 15; 136(10):3636-42. PubMed ID: 3009608
    [Abstract] [Full Text] [Related]

  • 2. Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.
    Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH.
    J Immunol; 1986 May 15; 136(10):3643-8. PubMed ID: 3009609
    [Abstract] [Full Text] [Related]

  • 3. Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma.
    Lotz M, Tsoukas CD, Fong S, Carson DA, Vaughan JH.
    Eur J Immunol; 1985 May 15; 15(5):520-5. PubMed ID: 2581792
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Herpesvirus seropositivity in childhood associates with decreased monocyte-induced NK cell IFN-gamma production.
    Saghafian-Hedengren S, Sundström Y, Sohlberg E, Nilsson C, Linde A, Troye-Blomberg M, Berg L, Sverremark-Ekström E.
    J Immunol; 2009 Feb 15; 182(4):2511-7. PubMed ID: 19201907
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR, Mason AT, Gerard JP, Henderson LE, Farrar W, Hopkins RF, Herberman RB, Rabin H.
    J Immunol; 1984 Aug 15; 133(2):779-83. PubMed ID: 6203980
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Regulation of murine lymphokine production in vivo. Ultraviolet radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1-dependent mechanism.
    Araneo BA, Dowell T, Moon HB, Daynes RA.
    J Immunol; 1989 Sep 15; 143(6):1737-44. PubMed ID: 2506268
    [Abstract] [Full Text] [Related]

  • 11. [IFN production by Epstein-Barr virus in human mononuclear leukocytes and suppression of the virus-induced transformation by the endogenous interferon].
    Kikuta H.
    Hokkaido Igaku Zasshi; 1986 Jan 15; 61(1):46-57. PubMed ID: 3009290
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.
    Orange JS, Biron CA.
    J Immunol; 1996 Jun 15; 156(12):4746-56. PubMed ID: 8648121
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M, Kato M, Ikeno K, Kobayashi T, Miyagawa Y, Komiyama A, Akabane T.
    Clin Exp Immunol; 1987 May 15; 68(2):251-8. PubMed ID: 2820633
    [Abstract] [Full Text] [Related]

  • 18. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K, Kinjo Y, Yara S, Uezu K, Koguchi Y, Tohyama M, Azuma M, Takeda K, Akira S, Saito A.
    Infect Immun; 2001 Nov 15; 69(11):6643-50. PubMed ID: 11598033
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J.
    Scand J Infect Dis Suppl; 1996 Nov 15; 100():72-82. PubMed ID: 8860357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.